Saratoga Health & Biotechnology Portfolio Fund Class Institutional
SBHIX
NASDAQ
| Weiss Ratings | SBHIX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Rating | ||||
| Reward Index | Good | |||
| Reward Grade | B | |||
| Risk Index | Fair | |||
| Risk Grade | C | |||
| Company Info | SBHIX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Provider | Saratoga | |||
| Manager/Tenure (Years) | Robert D. Stimpson (7) | |||
| Website | http://www.saratogacap.com/ | |||
| Fund Information | SBHIX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Fund Name | Saratoga Health & Biotechnology Portfolio Fund Class Institutional | |||
| Category | Health | |||
| Sub-Category | Healthcare Sector Equity | |||
| Prospectus Objective | Specialty - Health | |||
| Inception Date | Jan 28, 2003 | |||
| Open/Closed To New Investors | Open | |||
| Minimum Initial Investment | 250.00 | |||
| Minimum Subsequent Investment | -- | |||
| Front End Fee | -- | |||
| Back End Fee | -- | |||
| Dividends and Shares | SBHIX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Dividend Yield | 0.00% | |||
| Dividend | SBHIX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Dividend Yield (Forward) | 1.07% | |||
| Asset Allocation | SBHIX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Cash | 0.67% | |||
| Stock | 99.34% | |||
| U.S. Stock | 94.25% | |||
| Non-U.S. Stock | 5.09% | |||
| Bond | 0.00% | |||
| U.S. Bond | 0.00% | |||
| Non-U.S. Bond | 0.00% | |||
| Preferred | 0.00% | |||
| Convertible | 0.00% | |||
| Other Net | 0.00% | |||
| Price History | SBHIX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| 7-Day Total Return | 0.27% | |||
| 30-Day Total Return | -6.98% | |||
| 60-Day Total Return | -2.40% | |||
| 90-Day Total Return | -1.69% | |||
| Year to Date Total Return | -1.04% | |||
| 1-Year Total Return | 12.67% | |||
| 2-Year Total Return | 11.12% | |||
| 3-Year Total Return | 23.78% | |||
| 5-Year Total Return | 34.96% | |||
| Price | SBHIX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Closing Price | -- | |||
| 1-Month Low Price | -- | |||
| 1-Month High Price | -- | |||
| 52-Week Low Price | -- | |||
| 52-Week Low Price (Date) | -- | |||
| 52-Week High Price | -- | |||
| 52-Week High Price (Date) | -- | |||
| NAV | SBHIX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Nav | $25.58 | |||
| 1-Month Low NAV | $25.33 | |||
| 1-Month High NAV | $27.43 | |||
| 52-Week Low NAV | $21.64 | |||
| 52-Week Low NAV (Date) | Apr 08, 2025 | |||
| 52-Week High NAV | $27.50 | |||
| 52-Week High Price (Date) | Feb 27, 2026 | |||
| Beta / Standard Deviation | SBHIX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Beta | 0.54 | |||
| Standard Deviation | 12.69 | |||
| Balance Sheet | SBHIX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Total Assets | 11.61M | |||
| Operating Ratios | SBHIX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Expense Ratio | 2.60% | |||
| Turnover Ratio | 22.00% | |||
| Performance | SBHIX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Last Bull Market Total Return | 7.92% | |||
| Last Bear Market Total Return | -6.16% | |||